King Richard

Avg. Two Year Performance

91% Avg. Purchase Return
38% Compound
(6%) Avg. Sale Return
(3%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)(28%)(40%)(35%)91%
Purchase Success Rate0 of 10 of 10 of 10 of 11 of 1
Average Sale Return(2%)(6%)(12%)(7%)(6%)
Sale Success Rate2 of 112 of 111 of 111 of 111 of 11

Spruce Biosciences, Inc.

Other » Other

Chief Executive Officer, Director:

Holdings: 2.23K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Tercica Inc.

Other » Other

President and C.O.O.:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Adamas Pharmaceuticals Inc

Drugs » Drugs - Generic

Chief Operating Officer:

Holdings: 48.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Kos Pharmaceuticals Inc

»

EVP, Commercial Operations:

Holdings: 12.91K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

AcelRx Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 134.57K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--